Immunization of mice against West Nile virus with recombinant envelope protein

J Immunol. 2001 Nov 1;167(9):5273-7. doi: 10.4049/jimmunol.167.9.5273.

Abstract

West Nile (WN) virus is a mosquito-borne flavivirus that emerged in the United States in 1999 and can cause fatal encephalitis. Envelope (E) protein cDNA from a WN virus isolate recovered from Culex pipiens in Connecticut was expressed in Escherichia coli. The recombinant E protein was purified and used as Ag in immunoblot assays and immunization experiments. Patients with WN virus infection had Abs that recognized the recombinant E protein. C3H/HeN mice immunized with E protein developed E protein Abs and were protected from infection with WN virus. Passive administration of E protein antisera was also sufficient to afford immunity. E protein is a candidate vaccine to prevent WN virus infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Viral / immunology
  • Immunization
  • Mice
  • Mice, Inbred C3H
  • Recombinant Proteins / immunology
  • Vaccines, Synthetic / immunology*
  • Viral Envelope Proteins / immunology*
  • Viral Vaccines / immunology*
  • West Nile virus / immunology*

Substances

  • Antibodies, Viral
  • Recombinant Proteins
  • Vaccines, Synthetic
  • Viral Envelope Proteins
  • Viral Vaccines